A prominent NFL executive, speaking anonymously, argues that these high-profile acquisitions contribute to the 49ers’ injury woes. The executive contends that signing players with recent injury histories, such as Evans and Greenlaw, increases the likelihood of missed games and ongoing durability concerns for the team. Evans missed multiple games in recent seasons, while Greenlaw has appeared in a limited number of games over the last two years.
Supporters of the moves counter that Evans and Greenlaw, if healthy, could significantly bolster San Francisco’s offense and defense. Evans is praised for his downfield and possession-receiver capabilities, which could complement the 49ers’ offense by providing another reliable target for the quarterback. Greenlaw’s role as a versatile linebacker could help stabilize the defense, potentially allowing the team to sustain deep playoff runs if health holds.
The broader context remains: the NFC West should be competitive, and division titles are within reach if San Francisco can keep key players on the field. The 49ers already boast an accomplished core, and if Evans remains healthy, executives suggest their offense could be among the league’s most dangerous, with confident potential for improved efficiency in the passing game.
Overall, the discussion surrounding the 49ers’ offseason adds a cautious optimism to the franchise’s outlook. While the signings carry clear upside, their health will be a defining factor in determining whether San Francisco can convert playoff appearances into a sustained championship run in 2026. As training camps approach, observers will be watching closely to see if the added depth translates into durable, peak-level performance across the roster.
